Insider Trading July 10, 2026 04:33 PM

EverQuote CFO Joseph Sanborn Executes $164,208 Stock Sale Under Pre-Arranged Plan

Executive disposes of 6,667 shares as the company reports strong Q1 earnings and receives an upgraded price target from Raymond James.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
EVER

Joseph Sanborn, serving as both Chief Financial Officer and Chief Administrative Officer at EverQuote, Inc. (NASDAQ: EVER), has executed a transaction to sell 6,667 shares of the company's Class A Common Stock. The sale, which generated proceeds totaling $164,208, was conducted on July 8, 2026. The transaction was facilitated through a Rule 10b5-1 trading plan, a mechanism designed to allow insiders to trade company stock at predetermined times, which Sanborn initially adopted on December 4, 2025. The execution of this sale provides a specific data point regarding insider activity at the digital insurance marketplace, occurring against a backdrop of recent positive financial reporting and analyst sentiment.

EverQuote CFO Joseph Sanborn Executes $164,208 Stock Sale Under Pre-Arranged Plan
EVER
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • EverQuote CFO Joseph Sanborn sold 6,667 shares for $164,208 under a Rule 10b5-1 plan established in December 2025.
  • The company reported Q1 2026 earnings that beat expectations, with EPS of $0.51 and revenue of $190.85 million.
  • Raymond James raised its price target to $25.00, citing the expansion of AI-enabled product suites like SmartCampaigns.

Joseph Sanborn, who holds the dual roles of Chief Financial Officer and Chief Administrative Officer at EverQuote, Inc., has completed a significant transaction involving the company's equity. According to regulatory filings, Sanborn sold 6,667 shares of EverQuote's Class A Common Stock on July 8, 2026. The total value of this divestment was recorded at $164,208. The shares were executed at varying prices within a range of $24.18 to $25.14 per share.

This specific transaction was carried out under the parameters of a Rule 10b5-1 trading plan. This type of pre-arranged trading agreement allows corporate insiders to buy or sell stock at a set time, regardless of whether they possess material non-public information. Sanborn originally established this plan on December 4, 2025. The use of this plan indicates that the sale was part of a predetermined schedule rather than a reactive decision based on immediate market conditions.

Following the conclusion of this transaction, Sanborn's direct ownership stake in the company remains substantial. He continues to hold 311,908 shares of EverQuote Class A Common Stock directly. Furthermore, his indirect holdings include an additional 2,730 shares. These indirect shares are held in two separate Uniform Transfers to Minors Act (UTMA) accounts, which he manages as custodian for his first and second children, with 1,365 shares allocated to each account.

The insider activity occurs while EverQuote is trading at a price-to-earnings (P/E) ratio of 8.41. The company currently commands a market capitalization of approximately $875 million. Valuation metrics from InvestingPro analysis suggest that the stock may be trading below its intrinsic worth. The analysis places EverQuote among the most undervalued stocks in its sector, citing an "EXCELLENT" financial health score. The company's balance sheet is characterized by a position where cash holdings exceed debt obligations, a structure that typically provides liquidity buffers.

Recent financial results for EverQuote have demonstrated strong operational performance. The company reported earnings for the first quarter of 2026 that surpassed analyst consensus. EverQuote posted an earnings per share (EPS) of $0.51, which exceeded the forecasted figure of $0.44. This represented a positive surprise of 15.91% relative to expectations. Revenue performance also outpaced projections, with the company reporting $190.85 million against an expected $180.15 million.

Market sentiment has also seen a recent positive adjustment. Raymond James upgraded its price target for EverQuote shares to $25.00, increasing from a previous target of $20.00. The firm maintained an Outperform rating on the stock. Analyst C. Gregory Peters highlighted the company's strategic expansion of its AI-enabled product suite. Specifically, the growth of "SmartCampaigns" was noted for enhancing AI-powered bidding capabilities. This technology is designed to optimize return on ad spend for insurance carriers, reflecting ongoing strategic advancements in the company's operational model.

The intersection of insider selling, strong quarterly earnings, and analyst upgrades presents a complex picture for EverQuote. While the financial health metrics and valuation models suggest potential undervaluation, the executive sale under a 10b5-1 plan remains a distinct data point for investors monitoring insider positioning.

Risks

  • The execution of a stock sale by a C-suite executive, even under a pre-arranged plan, can be interpreted by the market as a lack of confidence in near-term stock appreciation.
  • Despite current undervaluation metrics and strong cash positions, EverQuote operates in the competitive insurance technology sector where rapid changes in AI bidding strategies could impact future margins.

More from Insider Trading

Globalharvest Holdings Expands Mission Produce Stake With $7.87 Million Share Purchase Jul 10, 2026 Riskified Director Shachar Erez Offloads $671K in Shares Under Pre-Arranged Plan Jul 10, 2026 Contineum Therapeutics CSO Executes Pre-Arranged Stock Sales Following Option Exercises Jul 10, 2026 Petco Health & Wellness CHRO Offloads $508K in Stock Amid Market Volatility Jul 10, 2026 Gloo Holdings Executive Chair Expands Stake Amid Public Offering Jul 10, 2026